Page last updated: 2024-08-17

bromodeoxyuridine and azd 6244

bromodeoxyuridine has been researched along with azd 6244 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ammoun, S; Hanemann, CO; Hilton, DA; Matthies, C; Ristic, N1
Denton, CL; Gustafson, DL1

Other Studies

2 other study(ies) available for bromodeoxyuridine and azd 6244

ArticleYear
Targeting ERK1/2 activation and proliferation in human primary schwannoma cells with MEK1/2 inhibitor AZD6244.
    Neurobiology of disease, 2010, Volume: 37, Issue:1

    Topics: Antineoplastic Agents; Benzimidazoles; Bromodeoxyuridine; Cell Proliferation; Cells, Cultured; Enzyme Inhibitors; Humans; Immunoblotting; Immunohistochemistry; MAP Kinase Kinase 2; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 3; Neurilemmoma; Phosphorylation; Platelet-Derived Growth Factor; Schwann Cells

2010
Pharmacokinetics and pharmacodynamics of AZD6244 (ARRY-142886) in tumor-bearing nude mice.
    Cancer chemotherapy and pharmacology, 2011, Volume: 67, Issue:2

    Topics: Animal Structures; Animals; Area Under Curve; Benzimidazoles; Bromodeoxyuridine; Cell Death; Cell Line, Tumor; Cell Proliferation; Extracellular Signal-Regulated MAP Kinases; Humans; Male; Melanoma; Mice; Mice, Inbred BALB C; Mice, Nude; Phosphorylation; Protein Kinase Inhibitors; Tissue Distribution; Xenograft Model Antitumor Assays

2011